Cargando…
The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study()
BACKGROUND: The novel coronavirus disease (COVID-19) emerged from China in 2019 and rapidly spread worldwide. Patients with metabolic comorbid conditions are more susceptible to infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Metabolic syndrome is a constellation of interl...
Autores principales: | Ghoneim, Sara, Butt, Muhammad Umer, Hamid, Osama, Shah, Aun, Asaad, Imad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480663/ https://www.ncbi.nlm.nih.gov/pubmed/32924000 http://dx.doi.org/10.1016/j.metop.2020.100057 |
Ejemplares similares
-
Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study
por: Ghoneim, Sara, et al.
Publicado: (2020) -
Metabolic impact of weight loss induced reduction of adipose ACE-2 – Potential implication in COVID-19 infections?
por: Li, Linna, et al.
Publicado: (2020) -
COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic
por: Tessier, Christopher M., et al.
Publicado: (2021) -
Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: Population-based, prospective cohort study
por: Hamer, Mark, et al.
Publicado: (2020) -
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)